TEM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tempus AI Inc (TEM) is not a strong buy for a beginner investor focused on long-term investment at this time. While there are some positive indicators such as hedge fund buying and a differentiated data offering, the lack of clarity around long-term monetization, mixed analyst sentiment, and widening operating losses make it prudent to hold off on buying. The absence of strong proprietary trading signals and recent price volatility further supports this conclusion.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 55.546, showing no overbought or oversold conditions. Moving averages are converging, which suggests indecision in the market. Key support and resistance levels are at 46.214 (S1) and 53.025 (R1), with the stock currently trading near its pivot point of 49.62.
Hedge funds are significantly increasing their buying activity, with an 884.13% increase over the last quarter. Analysts from TD Securities and TD Cowen are optimistic about Tempus AI's growth potential in the genomics and pharma AI sectors, citing strong fundamentals and attractive valuation.
Analysts have lowered price targets due to concerns about operating losses and lack of clear long-term monetization strategies. Jefferies has an Underperform rating, citing lack of clear catalysts and concerns in the diagnostics space. Insider trading activity is neutral, showing no significant confidence from company insiders.
No financial data available for analysis. However, analysts have noted widening operating losses despite sales growth in the latest quarter (Q1 2026).
Analyst sentiment is mixed. While some firms maintain Buy ratings with reduced price targets, others express concerns about Tempus AI's long-term monetization strategy and lack of clear catalysts. The price target range is wide, from $35 (Jefferies) to $80 (BTIG), reflecting uncertainty in the stock's future performance.
